Suppr超能文献

类Spalt转录因子4作为结直肠癌潜在的诊断和预后标志物。

Spalt-like transcription factor 4 as a potential diagnostic and prognostic marker of colorectal cancer.

作者信息

Wu Hong-Kun, Liu Chang, Fan Xiao-Xia, Wang Hao, Zhou Lin

出版信息

Cancer Biomark. 2017 Aug 23;20(2):191-198. doi: 10.3233/CBM-170204.

Abstract

OBJECTIVE

The study aimed to investigate the role of spalt-like transcription factor 4 (SALL4) in the diagnosis and prognosis of colorectal cancer (CRC).

METHODS

Between May 2008 and January 2010, 135 patients with CRC were recruited and subsequently assigned into the case group of the study. Additionally, 140 healthy individuals under identical conditions were selected as the control group. Venous blood was collected from all subjects. High expression of SALL4 was detected by immunohistochemistry, and SALL4 serum levels were detected using ELISA. A 5-year follow-up was conducted. A Kaplan-Meier curve was applied for analysis of survival rates, and a log-rank was used for univariate analysis.

RESULTS

The case group exhibited largely positive expression levels of SALL4. Levels of SALL4 serum were much higher than those in the control group. The AUC value of CRC detected by serum SALL4 was 0.916 (95% CI was 0.881-0.951), which regarded 0.1255 μcg/l to be the point of critical value. This result was in direct relation to data from the receiver operating characteristic curve (ROC). The sensitivity and specificity of serum SALL4 levels in the diagnosis of CRC were 85.9% and 85.7%, respectively. The AUC value of CRC detected by tissue SALL4 was 0.727 (95% CI was 0.666-0.789), 0.5 was regarded as the critical value. The sensitivity and specificity of SALL4 expression in CRC tissues regarding the diagnosis of CRC was determined to be 58.6% and 86.9% respectively. The levels of SALL4 expression in serum and tissues highlighted a correlation to lymph node metastasis (LNM), differentiation degree, Dukes staging and tumor node metastasis staging. Lower serum SALL4 levels were associated with higher survival rates in CRC patients. In accordance with a COX regression, LNM, differentiation degree and SALL4 levels were determined as being prognostic factors in patients with CRC (both P< 0.05).

CONCLUSION

Our experimental data indicated that over expression of SALL4 was found in CRC and low expression of SALL4 was connected with high survival rate after surgery. Thus our study suggested that SALL4 could serve as a potential diagnostic and prognostic marker of CRC.

摘要

目的

本研究旨在探讨锌指样转录因子4(SALL4)在结直肠癌(CRC)诊断及预后中的作用。

方法

2008年5月至2010年1月,招募了135例CRC患者并将其纳入研究的病例组。此外,选取140名条件相同的健康个体作为对照组。采集所有受试者的静脉血。采用免疫组化法检测SALL4的高表达情况,并用酶联免疫吸附测定法检测血清SALL4水平。进行为期5年的随访。应用Kaplan-Meier曲线分析生存率,并采用对数秩检验进行单因素分析。

结果

病例组SALL4表达水平大多呈阳性。血清SALL4水平远高于对照组。血清SALL4检测CRC的AUC值为0.916(95%CI为0.881 - 0.951),将临界值定为0.1255μg/l。该结果与来自受试者工作特征曲线(ROC)的数据直接相关。血清SALL4水平诊断CRC的敏感性和特异性分别为85.9%和85.7%。组织SALL4检测CRC的AUC值为0.727(95%CI为0.666 - 0.789),临界值定为0.5。CRC组织中SALL4表达对CRC诊断的敏感性和特异性分别为58.6%和86.9%。血清和组织中SALL4表达水平与淋巴结转移(LNM)、分化程度、Dukes分期及肿瘤淋巴结转移分期相关。CRC患者血清SALL4水平较低与较高的生存率相关。根据COX回归分析,LNM、分化程度和SALL4水平被确定为CRC患者的预后因素(均P < 0.05)。

结论

我们的实验数据表明,CRC中存在SALL4过表达,且SALL4低表达与术后高生存率相关。因此,我们的研究表明SALL4可作为CRC潜在的诊断和预后标志物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验